Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)-Reference-Cited by-同舟云学术

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)

Published:2001-12 Issue:4 Volume:115 Page:895-902
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Sonneveld P.,Suciu S.,Weijermans P.,Beksac M.,Neuwirtova R.,Solbu G.,Lokhorst H.,Van Der Lelie J.,Dohner H.,Gerhartz H.,Segeren C. M.,Willemze R.,Lowenberg B.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.03171.x/fullpdf

Reference28 articles.

1. Combination chemotherapy for multiple myeloma;Alexanian;Cancer,1972

2. Clinical significance of P-glycoprotein in multidrug resistance malignancies;Arceci;Blood,1993

3. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma;Attal;New England Journal of Medicine,1996

4. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma. detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy;Dalton;Journal of Clinical Oncology,1989

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma Burden;Cancer Research Communications;2024-04-09

2. Multidrug resistance protein 1 silencing in osteosarcoma and chondrosarcoma cell lines;Journal of Cancer Research and Therapeutics;2023

3. Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells;Biomedicines;2022-03-03

4. Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple Myeloma;ACS Pharmacology & Translational Science;2021-04-15

5. New uracil analog U-332 is an inhibitor of NF-κB in 5-fluorouracil-resistant human leukemia HL-60 cell line;BMC Pharmacology and Toxicology;2020-03-02